BeOne Medicines AG - Depositary Receipt (Common Stock)
US ˙ NasdaqGS ˙ US07725L1026

SecurityONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
InstitutionFranklin Resources Inc
Latest Disclosed Ownership201,641 shares
Latest Disclosed Value $ 59,881,349
Franklin Resources Inc reports 113.16% increase in ownership of ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)

On May 13, 2026 - Franklin Resources Inc filed a 13F-HR form disclosing ownership of 201,641 shares of BeOne Medicines AG - Depositary Receipt (Common Stock) (US:ONC) valued at $59,881,328 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 94,594 shares of BeOne Medicines AG - Depositary Receipt (Common Stock). This represents a change in shares of 113.16% during the quarter. The current value of the position is $56,257,839 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F BEONE MEDICINES SPONSORED ADS 07725L102 201,641 107,047 113.16 59,881 108.37 0.0024
2026-02-11 2025-12-31 13F BEONE MEDICINES SPONSORED ADS 07725L102 94,594 52,627 125.40 28,739 100.99 0.0071
2025-11-13 2025-09-30 13F BEONE MEDICINES SPONSORED ADS 07725L102 41,967 25,713 158.19 14,298 263.45 0.0036
2025-08-12 2025-06-30 13F BEONE MEDICINES SPONSORED ADS 07725L102 16,254 15,373 1,744.95 3,935 1,546.03 0.0010
2025-05-13 2025-03-31 13F BEIGENE SPONSORED ADS 07725L102 881 881 240 0.0001
2023-02-10 2022-12-31 13F BEIGENE SPONSORED ADR 07725L102 0 -2,767 -100.00 0 -100.00
2022-11-14 2022-09-30 13F BEIGENE SPONSORED ADR 07725L102 2,767 233 9.19 374 -8.78 0.0002
2022-08-11 2022-06-30 13F BEIGENE SPONSORED ADR 07725L102 2,534 42 1.69 410 -12.77 0.0002
2022-05-13 2022-03-31 13F BEIGENE SPONSORED ADR 07725L102 2,492 -30 -1.19 470 -31.29 0.0002
2022-02-11 2021-12-31 13F BEIGENE SPONSORED ADR 07725L102 2,522 -159 -5.93 684 -29.70 0.0002
2021-11-12 2021-09-30 13F BEIGENE SPONSORED ADR 07725L102 2,681 1,833 216.16 973 234.36 0.0004
2021-08-13 2021-06-30 13F BEIGENE SPONSORED ADR 07725L102 848 17 2.05 291 0.69 0.0001
2021-05-13 2021-03-31 13F BEIGENE SPONSORED ADR 07725L102 831 -5,374 -86.61 289 -81.98 0.0001
2021-02-10 2020-12-31 13F BEIGENE SPONSORED ADR 07725L102 6,205 5,071 447.18 1,604 393.54 0.0007
2020-11-12 2020-09-30 13F BEIGENE SPONSORED ADR 07725L102 1,134 1,134 325 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.